Drug Approval | December 05, 2025
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Patients can now get the starting 2.5 mg dose for $299 per month
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
The audit was completed with zero critical and zero major observations
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
Subscribe To Our Newsletter & Stay Updated
